Duration: (7:38) ?Subscribe5835 2025-02-08T07:59:23+00:00
Regeneron CEO: We want to retain efficacy and eliminate bad side effects with our cancer treatments
(7:6)
Regeneron CEO: Our antibody treatment helps immune system win battle
(4:10)
Leonard S. Schleifer, M.D., Ph.D., Founder and Chief Executive Officer, Regeneron Pharmaceuticals
(41:42)
AI is the big thing right now, but the real tool is genetics, says Regeneron CEO Dr. Schleifer
(2:15)
Regeneron to buy Sanofi's cancer drug in $1B deal
(8:31)
Q \u0026 A with Regeneron CEO, Dr. Leonard Schleifer '73 - 2019 Cornell Entrepreneur of the Year
(57:8)
Pepsi Aktie und Regeneron Aktie - Quartalszahlen. Pepsi zu günstig? Regeneron meldet Dividende
(13:56)
General Session: George D. Yancopoulos, Regeneron and Matt Herper, STAT
(21:34)
Seeing the buildup of an inventory cycle in tech, says Richard Bernstein Advisors CEO
(4:21)
Novo Nordisk CEO Lars Fruergaard Jørgensen on Q4 results, Wegovy demand and drug pipeline outlook
(7:56)
Regeneron’s Mission
(4:51)
Our Culture
(3:18)
ChemE's Wang Lecture - George Yancopoulos
(1:28:51)
These are the stocks to buy for the next 10 years
(5:32)
31st Annual Leadership 100 Conference, Forum Speaker Dr. George D. Yancopoulos
(44:55)
REGN Stock Review | Regeneron Stock Warren Buffett Fair Value
(12:41)
Watch CNBC's full interview with Regeneron CEO Len Schleifer
(4:32)
Regeneron Pharmaceuticals, Inc. (REGN) Q4 2024 Earnings Call \u0026 Full Presentation
(1:8:18)
Regeneron: The Path from Basic Research to Commercial Product
(2:2:44)
Arm CEO Rene Haas Talks Company Outlook | Bloomberg Talks
(6:37)
Regeneron CEO: We'll likely have to constantly adapt our antibody cocktail
Regeneron CEO Explains the High Cost of Cholesterol Drug Praluent
(2:57)
Regeneron CEO on the prospects for its eye drug Eylea
(3:29)
Regeneron CEO on coronavirus drug timeline
(7:38)
Regeneron CEO Leonard Schleifer: Changing The Paradigm On Drug Access And Pricing | CNBC
(8:35)
Regeneron CEO: Antibody cocktail offered to Biden's team
(1:29)
Regeneron Pharmaceuticals CEO: Changing Medicine | Mad Money | CNBC
(6:34)
Dr. Oz Asks The Co-Founder Of Regeneron How His Company’s Antibody Cocktail Works.
(40)
Founder Stories: Founders of Regeneron, one of the world’s greatest drug developers
Regeneron CEO on FDA request for expanded EUA of Covid antibody drug
(6:23)